131 related articles for article (PubMed ID: 6181363)
1. Serological markers of hepatitis B virus and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos.
Heyward WL; Bender TR; Lanier AP; Francis DP; McMahon BJ; Maynard JE
Lancet; 1982 Oct; 2(8304):889-91. PubMed ID: 6181363
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
[TBL] [Abstract][Full Text] [Related]
3. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
[TBL] [Abstract][Full Text] [Related]
4. HBeAg/anti-HBe and alpha-fetoproteins levels in primary hepatocellular carcinoma.
Liaw YF
Lancet; 1982 Dec; 2(8313):1458. PubMed ID: 6184587
[No Abstract] [Full Text] [Related]
5. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
[TBL] [Abstract][Full Text] [Related]
6. The detection of alpha-fetoprotein in HBs Ag and HBe Ag carriers.
Panoyotopoulos S; Yiannacopoulos T; Margari-Papanicolaou P; Christou A
Allergol Immunopathol (Madr); 1982; 10(1):1-4. PubMed ID: 6177229
[TBL] [Abstract][Full Text] [Related]
7. Is anti-HBc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?
Lai MC; Tong MJ; Nowicki MJ; Lee SD
Hepatology; 1988; 8(3):514-7. PubMed ID: 2453429
[TBL] [Abstract][Full Text] [Related]
8. Primary hepatocellular carcinoma in intertropical Africa: relationship between age and hepatitis B virus etiology.
Coursaget P; Maupas P; Goudeau A; Chiron JP; Drucker J; Denis F; Diop-Mar I
J Natl Cancer Inst; 1980 Oct; 65(4):687-90. PubMed ID: 6158589
[TBL] [Abstract][Full Text] [Related]
9. IgM antibody to hepatitis B core antigen in Korean patients with hepatocellular carcinoma.
Sjogren MH; Lemon SM; Chung WK; Sun HS; Hoofnagle JH
Hepatology; 1984; 4(4):615-8. PubMed ID: 6204916
[TBL] [Abstract][Full Text] [Related]
10. Early detection of primary hepatocellular carcinoma by screening for alpha-fetoprotein in high-risk families. A case-report.
Heyward WL; Lanier AP; Bender TR; McMahon BJ; Kilkenny S; Paprocki TR; Kline KT; Silimperi DR; Maynard JE
Lancet; 1983 Nov; 2(8360):1161-2. PubMed ID: 6196582
[TBL] [Abstract][Full Text] [Related]
11. Primary hepatocellular carcinoma and hepatitis B virus infection in Korea.
Chung WK; Sun HS; Park DH; Minuk GY; Hoofnagle JH
J Med Virol; 1983; 11(2):99-104. PubMed ID: 6188801
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
[TBL] [Abstract][Full Text] [Related]
13. Detection of alpha-fetoprotein and hepatitis-B surface antigen in blood spotted on filter paper: use as a screen for hepatocellular carcinoma in Alaska Natives.
Parkinson AJ; McMahon BJ; Zanis L; Lanier AP; Wainwright RB
Arctic Med Res; 1996 Jul; 55(3):123-8. PubMed ID: 8885434
[TBL] [Abstract][Full Text] [Related]
14. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Liaw YF; Chu CM; Lin DY; Sheen IS; Yang CY; Huang MJ
J Med Virol; 1984; 13(4):385-91. PubMed ID: 6330293
[TBL] [Abstract][Full Text] [Related]
15. Early detection of primary hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among persons infected with hepatitis B virus.
Heyward WL; Lanier AP; McMahon BJ; Fitzgerald MA; Kilkenny S; Paprocki TR
JAMA; 1985 Dec; 254(21):3052-4. PubMed ID: 2414477
[TBL] [Abstract][Full Text] [Related]
16. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.
McMahon BJ; Holck P; Bulkow L; Snowball M
Ann Intern Med; 2001 Nov; 135(9):759-68. PubMed ID: 11694101
[TBL] [Abstract][Full Text] [Related]
17. Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers.
Lieberman HM; LaBrecque DR; Kew MC; Hadziyannis SJ; Shafritz DA
Hepatology; 1983; 3(3):285-91. PubMed ID: 6301965
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus e antigen and primary hepatocellular carcinoma.
Lin TM; Chen CJ; Lu SN; Chang AS; Chang YC; Hsu ST; Liu JY; Liaw YF; Chang WY
Anticancer Res; 1991; 11(6):2063-5. PubMed ID: 1663719
[TBL] [Abstract][Full Text] [Related]
19. Primary hepatocellular carcinoma in Alaskan natives, 1969-1979.
Heyward WL; Lanier AP; Bender TR; Hardison HH; Dohan PH; McMahon BJ; Francis DP
Int J Cancer; 1981 Jul; 28(1):47-50. PubMed ID: 6273329
[TBL] [Abstract][Full Text] [Related]
20. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.
Hadziyannis SJ; Lieberman HM; Karvountzis GG; Shafritz DA
Hepatology; 1983; 3(5):656-62. PubMed ID: 6618432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
